Active Biotech Overview
- Year Founded
-
1996
- Status
-
Public
- Employees
-
5
- Stock Symbol
-
ACTI
- Share Price
-
$0.35
- (As of Friday Closing)
Active Biotech General Information
Description
Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy. Its project portfolio includes both small orally active immunomodulatory molecules and antibody-based immunotherapy. Its pipeline products are: Tasquinimod, Laquinimod, and Naptumomab.
Contact Information
Website
www.activebiotech.comCorporate Office
- Scheelevägen 22
- 223 63 Lund
- Sweden
Corporate Office
- Scheelevägen 22
- 223 63 Lund
- Sweden
Active Biotech Stock Performance
As of 13-Nov-2026, Active Biotech’s stock price is $0.35. Its current market cap is $9.3M with 26.4M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.35 | $0.35 | $0.31 - $1.02 | $9.3M | 26.4M | 56.5K | -$0.21 |
Active Biotech Financials Summary
As of 30-Sep-2026, Active Biotech has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 6,025 | 12,210 | 9,970 | 15,963 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (3,725) | (3,669) | (3,615) | (4,156) |
| Net Income | (3,821) | (3,799) | (3,725) | (4,309) |
| Total Assets | 4,112 | 7,630 | 3,914 | 4,407 |
| Total Debt | 0 | 189 | 289 | 455 |
Active Biotech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Active Biotech Comparisons
Industry
Financing
Details
Active Biotech Competitors (40)
One of Active Biotech’s 40 competitors is Genfit, a Formerly VC-backed company based in Loos, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genfit | Formerly VC-backed | Loos, France | ||||
| Immunocore Holdings | Formerly VC-backed | Abingdon, United Kingdom | ||||
| Idorsia Pharmaceuticals | Corporation | Allschwil, Switzerland | ||||
| Sorrento Therapeutics | Formerly VC-backed | San Diego, CA | ||||
| Aprea Therapeutics | Formerly VC-backed | Doylestown, PA |
Active Biotech Patents
Active Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025006886-A1 | Quinoline carboxamides for use in the treatment of men | Inactive | 28-Jun-2023 | ||
| AU-2024306742-A1 | Quinoline carboxamides for use in the treatment of mpn | Pending | 28-Jun-2023 | ||
| EP-4734995-A1 | Quinoline carboxamides for use in the treatment of mpn | Pending | 28-Jun-2023 | ||
| WO-2025006886-A9 | Quinoline carboxamides for use in the treatment of mpn | Inactive | 28-Jun-2023 | ||
| AU-2022303084-A1 | A pharmaceutical product containing tasquinimod and a method for assessing the purity of said product | Pending | 02-Jul-2021 | A61K31/4704 |
Active Biotech Signals
Active Biotech Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Active Biotech ESG
Risk Overview
Risk Rating
Updated June, 30, 2023
28.12 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,766
Rank
Percentile
Pharmaceuticals
Industry
of 891
Rank
Percentile
Biotechnology
Subindustry
of 394
Rank
Percentile
Active Biotech FAQs
-
When was Active Biotech founded?
Active Biotech was founded in 1996.
-
Where is Active Biotech headquartered?
Active Biotech is headquartered in Lund, Sweden.
-
What is the size of Active Biotech?
Active Biotech has 5 total employees.
-
What industry is Active Biotech in?
Active Biotech’s primary industry is Drug Discovery.
-
Is Active Biotech a private or public company?
Active Biotech is a Public company.
-
What is Active Biotech’s stock symbol?
The ticker symbol for Active Biotech is ACTI.
-
What is the current stock price of Active Biotech?
As of 13-Nov-2026 the stock price of Active Biotech is $0.35.
-
What is the current market cap of Active Biotech?
The current market capitalization of Active Biotech is $9.3M.
-
Who are Active Biotech’s competitors?
Genfit, Immunocore Holdings, Idorsia Pharmaceuticals, Sorrento Therapeutics, and Aprea Therapeutics are some of the 40 competitors of Active Biotech.
-
What is Active Biotech’s annual earnings per share (EPS)?
Active Biotech’s EPS for 12 months was -$0.21.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process